Cardiol Therapeutics Class Stock Volatility
| CRDL Stock | CAD 3.81 0.24 6.72% |
Cardiol Therapeutics is very risky given 3 months investment horizon. Cardiol Therapeutics secures Sharpe Ratio (or Efficiency) of 0.2, which signifies that the company had a 0.2% return per unit of risk over the last 3 months. We were able to interpolate twenty-nine different technical indicators, which can help you to evaluate if expected returns of 1.07% are justified by taking the suggested risk. Use Cardiol Therapeutics Downside Deviation of 4.8, mean deviation of 4.13, and Risk Adjusted Performance of 0.0753 to evaluate company specific risk that cannot be diversified away. Key indicators related to Cardiol Therapeutics' volatility include:
30 Days Market Risk | Chance Of Distress | 30 Days Economic Sensitivity |
Cardiol Therapeutics Stock volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of Cardiol daily returns, and it is calculated using variance and standard deviation. We also use Cardiol's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of Cardiol Therapeutics volatility.
Cardiol |
Since volatility provides investors with entry points to take advantage of stock prices, companies, such as Cardiol Therapeutics can benefit from it. Downward market volatility can be a perfect environment for investors who play the long game. Here, they may decide to buy additional stocks of Cardiol Therapeutics at lower prices. For example, an investor can purchase Cardiol stock that has halved in price over a short period. This will lower your average cost per share, thereby improving your portfolio's performance when the markets normalize. Similarly, when the prices of Cardiol Therapeutics' stock rises, investors can sell out and invest the proceeds in other equities with better opportunities. Investing when markets are volatile with better valuations will accord both investors and companies the opportunity to generate better long-term returns.
Moving together with Cardiol Stock
Moving against Cardiol Stock
| 0.77 | SALT | Atlas Salt | PairCorr |
| 0.7 | STUD | Stallion Gold Corp | PairCorr |
| 0.62 | BABY | Else Nutrition Holdings | PairCorr |
| 0.55 | CDR | Condor Energies | PairCorr |
Cardiol Therapeutics Market Sensitivity And Downside Risk
Cardiol Therapeutics' beta coefficient measures the volatility of Cardiol stock compared to the systematic risk of the entire market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents Cardiol stock's returns against your selected market. In other words, Cardiol Therapeutics's beta of -1.18 provides an investor with an approximation of how much risk Cardiol Therapeutics stock can potentially add to one of your existing portfolios. Cardiol Therapeutics Class exhibits above-average semi-deviation for your current time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Cardiol Therapeutics' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Cardiol Therapeutics' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.
3 Months Beta |Analyze Cardiol Therapeutics Demand TrendCheck current 90 days Cardiol Therapeutics correlation with market (NYSE Composite)Cardiol Beta |
Cardiol standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. A typical volatile entity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.
Standard Deviation | 5.38 |
It is essential to understand the difference between upside risk (as represented by Cardiol Therapeutics's standard deviation) and the downside risk, which can be measured by semi-deviation or downside deviation of Cardiol Therapeutics' daily returns or price. Since the actual investment returns on holding a position in cardiol stock tend to have a non-normal distribution, there will be different probabilities for losses than for gains. The likelihood of losses is reflected in the downside risk of an investment in Cardiol Therapeutics.
Cardiol Therapeutics Stock Volatility Analysis
Volatility refers to the frequency at which Cardiol Therapeutics stock price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with Cardiol Therapeutics' price changes. Investors will then calculate the volatility of Cardiol Therapeutics' stock to predict their future moves. A stock that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A stock with relatively stable price changes has low volatility. A highly volatile stock is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of Cardiol Therapeutics' volatility:
Historical Volatility
This type of stock volatility measures Cardiol Therapeutics' fluctuations based on previous trends. It's commonly used to predict Cardiol Therapeutics' future behavior based on its past. However, it cannot conclusively determine the future direction of the stock.Implied Volatility
This type of volatility provides a positive outlook on future price fluctuations for Cardiol Therapeutics' current market price. This means that the stock will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on Cardiol Therapeutics' to be redeemed at a future date.Transformation |
The output start index for this execution was zero with a total number of output elements of sixty-one. Cardiol Therapeutics Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input.
Cardiol Therapeutics Projected Return Density Against Market
Assuming the 90 days trading horizon Cardiol Therapeutics Class has a beta of -1.1756 suggesting as returns on its benchmark rise, returns on holding Cardiol Therapeutics Class are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Cardiol Therapeutics is expected to outperform its benchmark.Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Cardiol Therapeutics or Pharmaceuticals sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Cardiol Therapeutics' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Cardiol stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Cardiol Therapeutics Class has an alpha of 0.6286, implying that it can generate a 0.63 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta). Predicted Return Density |
| Returns |
What Drives a Cardiol Therapeutics Price Volatility?
Several factors can influence a stock's market volatility:Industry
Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.Political and Economic environment
When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.The Company's Performance
Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.Cardiol Therapeutics Stock Risk Measures
Assuming the 90 days trading horizon the coefficient of variation of Cardiol Therapeutics is 503.31. The daily returns are distributed with a variance of 28.97 and standard deviation of 5.38. The mean deviation of Cardiol Therapeutics Class is currently at 3.87. For similar time horizon, the selected benchmark (NYSE Composite) has volatility of 0.63
α | Alpha over NYSE Composite | 0.63 | |
β | Beta against NYSE Composite | -1.18 | |
σ | Overall volatility | 5.38 | |
Ir | Information ratio | 0.1 |
Cardiol Therapeutics Stock Return Volatility
Cardiol Therapeutics historical daily return volatility represents how much of Cardiol Therapeutics stock's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The firm accepts 5.3826% volatility on return distribution over the 90 days horizon. By contrast, NYSE Composite accepts 0.6297% volatility on return distribution over the 90 days horizon. Performance |
| Timeline |
About Cardiol Therapeutics Volatility
Volatility is a rate at which the price of Cardiol Therapeutics or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of Cardiol Therapeutics may increase or decrease. In other words, similar to Cardiol's beta indicator, it measures the risk of Cardiol Therapeutics and helps estimate the fluctuations that may happen in a short period of time. So if prices of Cardiol Therapeutics fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.| Last Reported | Projected for Next Year | ||
| Market Cap | 70.9 M | 90.9 M |
Cardiol Therapeutics' stock volatility refers to the amount of uncertainty or risk involved with the size of changes in its stock's price. It is a statistical measure of the dispersion of returns on Cardiol Stock over a specified period of time, often expressed as the standard deviation of daily returns. In other words, it measures how much Cardiol Therapeutics' price varies over time.
3 ways to utilize Cardiol Therapeutics' volatility to invest better
Higher Cardiol Therapeutics' stock volatility means that the price of its stock is changing rapidly and unpredictably, while lower stock volatility indicates that the price of Cardiol Therapeutics stock is relatively stable. Investors and traders use stock volatility as an indicator of risk and potential reward, as stocks with higher volatility can offer the potential for more significant returns but also come with a greater risk of losses. Cardiol Therapeutics stock volatility can provide helpful information for making investment decisions in the following ways:- Measuring Risk: Volatility can be used as a measure of risk, which can help you determine the potential fluctuations in the value of Cardiol Therapeutics investment. A higher volatility means higher risk and potentially larger changes in value.
- Identifying Opportunities: High volatility in Cardiol Therapeutics' stock can indicate that there is potential for significant price movements, either up or down, which could present investment opportunities.
- Diversification: Understanding how the volatility of Cardiol Therapeutics' stock relates to your other investments can help you create a well-diversified portfolio of assets with varying levels of risk.
Cardiol Therapeutics Investment Opportunity
Cardiol Therapeutics Class has a volatility of 5.38 and is 8.54 times more volatile than NYSE Composite. 47 percent of all equities and portfolios are less risky than Cardiol Therapeutics. You can use Cardiol Therapeutics Class to enhance the returns of your portfolios. The stock experiences a very speculative upward sentiment. Check odds of Cardiol Therapeutics to be traded at C$4.76 in 90 days.Good diversification
The correlation between Cardiol Therapeutics Class and NYA is -0.13 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Cardiol Therapeutics Class and NYA in the same portfolio, assuming nothing else is changed.
Cardiol Therapeutics Additional Risk Indicators
The analysis of Cardiol Therapeutics' secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in Cardiol Therapeutics' investment and either accepting that risk or mitigating it. Along with some common measures of Cardiol Therapeutics stock's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Risk Adjusted Performance | 0.0753 | |||
| Market Risk Adjusted Performance | (0.50) | |||
| Mean Deviation | 4.13 | |||
| Semi Deviation | 4.38 | |||
| Downside Deviation | 4.8 | |||
| Coefficient Of Variation | 945.43 | |||
| Standard Deviation | 5.75 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential stocks, we recommend comparing similar stocks with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Cardiol Therapeutics Suggested Diversification Pairs
Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Cardiol Therapeutics as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Cardiol Therapeutics' systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Cardiol Therapeutics' unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Cardiol Therapeutics Class.
Additional Information and Resources on Investing in Cardiol Stock
When determining whether Cardiol Therapeutics is a strong investment it is important to analyze Cardiol Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Cardiol Therapeutics' future performance. For an informed investment choice regarding Cardiol Stock, refer to the following important reports:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cardiol Therapeutics Class. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.